Back to
Temasek Holdings (Private) Ltd
CHRS
Showing 1 of 24 quarters
Position history for
Temasek Holdings (Private) Ltd's holdings in COHERUS ONCOLOGY INC
No. Temasek Holdings (Private) exited its CHRS (Coherus Oncology) position in Q3 2024. Its Q2 2024 13F listed 5,818,802 shares worth $10.1M. Temasek Holdings (Private) already held CHRS in its Q4 2018 13F, the earliest on record, and held it in 23 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History